Research and Markets has announced the addition of the "Electronic Health Records - Charting the Future of Health Care" report to their offering.
Electronic Health Records have been in limited use since the 1960s, but their adoption received a major boost when they became more of a focus for the US government. In 2004, President Bush put forth the goal of having every American covered by an EHR within 10 years. In 2009, President Obama added the key element of funding under the American Recovery and Reinvestment Act. The EHR Meaningful Use Incentive programs funded under the ARA were further bolstered by programs in the 2010 health care reform legislation which promoted Accountable Care Organizations.
After the results of the November elections and the Supreme Court's ruling upholding the individual mandate, the future for health care reform would look more sure. However, recently some Republican members of congress have turned their attention to EHR programs, questioning whether they are an effective use of funding.
The report, Electronic Health Records - Charting the Future of Health Care, was designed to provide insights and analysis on a topic that is being felt from government agencies to treating physicians, while also impacting the pharmaceutical industry. CBR Pharma Insights not only provides in-depth analysis on the technology being used, the adoption of this technology, and the trends being seen locally and globally, but also how EHRs could impact pharmaceutical companies.
Key Reasons to Purchase
Understand and evaluate the criticisms behind the use of Electronic Health Records
Analyze the challenges facing Electronic Health Records adoption
Understand the role government has played in the development of Electronic Health Records in the US and the debates that are currently taking place over their use
Gain insights around the attempts being made to develop Electronic Health Records systems throughout the world, where they are showing positive signs of success, and where more work needs to be done
Assess the potential benefits of the use of Electronic Health Records for the pharmaceutical industry and the opportunities that exist for your company
Key Topics Covered:
Executive Summary
Chapter 1: Development of Electronic Health Records
Pre-reform programs
2010 Health Care reform programs for EHRs
Meaningful Use incentive programs
Post-election direction for EHRs
Chapter 2: Technology
Mobile technology
HIPAA and privacy
Chapter 3: Adoption of EHRs
Physician opinions
Impact on the physician-patient relationship
Implementation challenges
Chapter 4: Impact of EHR use
Case study: Diagnostic imaging
Case study: preventative care
Case study: drug safety
Chapter 5: EHR use outside of the US
Europe
Asia
Emerging markets
Lessons of implementation
Chapter 6: The outlook for EHRs
Billing
Cloning
For more information visit http://www.researchandmarkets.com/research/6lk384/electronic_health
Research and Markets
Laura Wood, Senior Manager.
press(at)researchandmarkets(dot)com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Hospital Information Systems
Orignal From: Research and Markets: Electronic Health Records: Charting the Future of Health Care - 2013 Report
No comments:
Post a Comment